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How Arsenic Acts
Evidence of Oxidative Stress
Scientists have known that people chronically exposed to excessive
levels of arsenic in drinking water can suffer skin sores, hyperten-
sion, and peripheral vascular disease, plus have a higher risk for
certain cancers. Arsenic’s mechanism of action in human illness
has been unclear, but laboratory studies of cells and animals have
shown that exposure to arsenic causes oxidative stress, a condition
that damages cellular health and is a culprit in the development of
many diseases. This month, a group of Chinese, Japanese, and
U.S. scientists led by Jingbo Pi of the University of Tsukuba in
Japan provide evidence that exposure to arsenic in drinking water
results in oxidative stress in humans as well [EHP 110:331–336].
The team studied 43 residents in Wuyuan, Inner Mongolia,
China. The study subjects, all members of the Han nationality,
received their main arsenic exposure through groundwater, having
drunk tube-well water for a mean duration of about 18 years. 
The high-exposure group included 33 residents of Yindingtu
and Shiba, two villages where tests of tube-well water showed that,
at 0.41 mg/L, mean concentrations of inorganic arsenic were
about 8.2 times higher than China’s regulatory limit for drinking
water and 41 times higher than the World Health Organization’s
guidelines for drinking water. These subjects showed various com-
mon symptoms of arsenic poisoning, including unusual loss or
overgrowth of pigmentation, hyperkeratosis (a thickening of the
outer skin), higher rates of peripheral vascular disorder, peripheral
neuropathy, and liver swelling. The low-exposure comparison
group included 10 residents from the village of Shahe, 35 miles
away, who drank tube-well water with much lower arsenic con-
centrations (0.02 mg/L).
Two physicians questioned the subjects on their lifetime
drinking water sources, health care history, diet, and use of alco-
hol and cigarettes. Two dermatologists, blinded with respect to
arsenic exposure in the study participants, conducted physical
examinations. Blood was drawn from the study participants, and
serum was separated to measure lipid peroxide levels. 
The team found that participants in the high-exposure group
had significantly higher levels of lipid peroxide in serum—
24.0% higher—compared to the low-exposure group. Lipid per-
oxide is a product of lipid oxidized by free radicals, chemicals
that rapidly react with other chemicals, damaging cellular DNA
and playing an important role in processes such as mutagenesis,
carcinogenesis, and aging. An elevated lipid peroxide profile
indicates oxidative stress.
Another indicator of oxidative stress in the high-exposure
group was the subjects’ nonprotein sulfhydryl (NPSH) mean
concentration in whole blood. NPSH plays an important role in
protecting against damage by free radicals—approximately 95%
of NPSH is the antioxidant glutathione, which can scavenge free
radicals, or bring about enzymatic and chemical changes that
trap free radicals before they damage DNA and RNA. The high-
exposure group showed mean blood NPSH concentrations that
were 57.3% of those in the low-exposure group. 
The authors suggest that NPSH depletion might have
encouraged lipid peroxides to proliferate in the high-exposure
group, or the subjects’ NPSH might have become depleted
because of overproduced free radicals caused by exposure to
arsenic. While the precise mechanism needs further study,
chronic exposure to arsenic in drinking water was clearly shown
to induce oxidative stress.–John Tibbetts
POP Surprise
Wood Preservative Persists in Plasma
Exposure to low concentrations of polychlorinated biphenyls
(PCBs) in the womb has been linked with adverse neurodevelop-
mental effects in humans and animals. It has been hypothesized
recently that hydroxylated PCB metabolites, or HO-PCBs, may be
the actor behind these adverse effects. So Courtney D. Sandau, for-
merly of Carleton University in Ottawa, and a team of Canadian
scientists set out to evaluate the potential health effects of in utero
exposure to HO-PCBs and other halogenated phenolic compounds
[EHP 110:411–417]. Although HO-PCBs were indeed correlated
with signs of thyroid disruption, another phenolic compound
turned out to be the surprise leader in terms of how commonly it
showed up in cord blood samples.
Because the symptoms of PCB exposure can overlap with those
of thyroid dysfunction, several investigators have speculated that the
neurologic consequences of incidental exposure to PCBs are caused
by thyroid disruption. Sandau and colleagues hypothesize that HO-
PCBs may play a critical role in this effect. These metabolites have
very high binding affinities to transthyretin, the protein that trans-
ports thyroid hormones across the blood–brain barrier to the devel-
oping brain; in fact, they can have up to 12 times the binding affinity
of thyroxine, the ligand that normally binds to this protein.
Although PCB concentrations have been previously measured in
umbilical cord plasma, this is the first study to examine HO-PCBs
and other phenolic compounds in that medium.
The scientists looked at concentrations of PCBs, a number of
HO-PCBs, and other phenolic compounds such as pen-
tachlorophenol (PCP), which also are known to have a high
binding affinity for transthyretin. They measured these com-
pounds in 10 randomly selected umbilical cord plasma samples
from each of three regions in Canada. The people living in the
three different regions have different diets and thus different PCB
exposures. People in Québec City, Québec, have background
PCB exposures similar to those of the general population of
Canada. Nunavik Inuit eat seal and beluga whale blubber, which
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Arsenic investigation. Studies of blood serum of people in China
with a history of drinking arsenic-contaminated well water revealed










have high PCB concentrations. Subsistence fishers along the
Lower North Shore of eastern Québec eat fish, sea mammals,
and seabird eggs, giving them an intermediate level of exposure.
The samples came from various umbilical cord blood surveys, so
there was no standard health history or other gathering of infor-
mation to accompany them.
Unexpectedly, the scientists found that one of the most abun-
dant persistent organic pollutants found in umbilical cord plasma
was not an HO-PCB but the wood preservative PCP. PCP concen-
trations ranged from 628 to 7,680 pg/g wet weight in plasma and
did not vary significantly across regions. PCP represented an aver-
age of 66–82% of the concen-
tration of all phenolic com-
pounds in each region. HO-
PCB concentrations, as expect-
ed, made up about 10% of
total PCBs. 
PCP, used in wood preser-
vatives, biocides, and disinfec-
tants, is not banned in the
United States or Canada.
Other recent studies have
found PCP to be the dominant
phenolic compound in whole
blood from Inuits as well as
Latvian and Swedish fish
eaters. Food is unlikely to be a
major source of PCP because it
is a volatile, soluble com-
pound; it is found in air and
water, but it does not accumu-
late in animal tissues. 
Despite the small sample
size, Sandau’s team found a
weak negative association between total phenolic compounds and
free thyroxine concentrations, suggesting that PCP and HO-PCBs
may alter indeed thyroid status in newborns, perhaps by disrupting
thyroid hormone metabolism. The U.S. Centers for Disease
Control and Prevention (where Sandau now works) and their col-
laborators at Laval University in Québec will be looking for confir-
mation of these results on a larger population later this year.
–Rebecca Renner
Lead in the Average Joe
No Increase in Cancer Risk
Although classified as a possible carcinogen in humans, lead is an
established carcinogen in experimental animals; the administration
of inorganic lead in rats and mice has resulted in kidney, nervous
system, and lung tumors. So far, however, a definitive blood
lead–cancer relationship has not been established in humans. In
this issue, Ahmedin Jemal of the National Cancer Institute and his
colleagues investigated the association between blood lead concen-
trations and cancer mortality among Caucasians (whites) in the
general U.S. population [EHP 110:325–329]. Although a mild
dose–response relationship was noted among women with very
high blood lead concentrations, none of the site-specific cancers
examined showed a statistically significant increase in risk with
chronic lead exposure.
Many of the epidemiologic studies that relate lead with cancer
have been conducted in occupational settings; no previous study is
known to have examined the association between lead and cancer
in the general population. Jemal and colleagues  used data from
the National Health and Nutrition Examination Survey
(NHANES) II Mortality Study of 1992, which was designed to
examine the association between factors measured at baseline with
overall or cause-specific mortality among a large general popula-
tion. They restricted their study to whites because both blood lead
concentrations and cancer deaths vary by race, and the number of
deaths in other races in the Mortality Study was too small to pro-
vide reliable estimates.
The researchers investigated a total of 203 cancer deaths (117 men, 86
women) among 3,592 white people, with an average followup of 13.3 years
until death from cancer. They used
a statistical method known as Cox
proportional hazard regression
modeling to estimate dose–response
relationships between blood lead
and all cancer mortality. Relative
risks were estimated for site-specific
cancers (such as kidney tumors) by
categorizing blood lead concentra-
tions as high, medium, and low (for
classification into groups only). The
study also took into account nutri-
tion, consumption of alcoholic bev-
erages, and tobacco use.
A statistical test of data
from the followup period
indicated that cancer risks did
not increase with increasing
blood lead concentrations
among men and women com-
bined and among men alone,
but there was a marginally sig-
nificant increase among
women alone. Women seemed to show a possible threshold
effect at about the 94th percentile of lead, which corresponds to
a blood concentration of 24 µg/dL among all study subjects.
Further evaluation among women, however, showed virtually
similar relative risks. 
With respect to the association of blood lead concentration
with selected site-specific cancer mortality, none of the site-spe-
cific cancers showed a statistically significant excess risk with ele-
vated concentrations. Among the combined sexes and men, risks
did increase with increases in blood lead concentration, but not
significantly for prostate cancers among men and brain cancers
among both sexes. Among women, there was no clear pattern.
Jemal lists several limitations in the database and analyses
used. For instance, in the Mortality Study, people not known to
be deceased were assumed to be alive; thus, a misclassification of
vital status was possible. Also, measurement of blood lead
occurred once and may not reflect cumulative exposure, but pro-
vides only an approximation. This becomes important because
blood lead concentrations have been decreasing in the U.S. popu-
lation, due, for instance, to the discontinued use of leaded gaso-
line, paint, and solder.
Whether lead causes cancer in humans is thus still not well
established. The apparent dose–response relationship found in
women with the highest blood lead concentrations could be
either a chance finding or attributable to certain confounding fac-
tors. The authors write that this finding “has no clear biologic
explanation; further studies of populations with sufficiently high
lead exposure are needed to replicate the finding among women
before it is believable.”–Julian Josephson
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Reason to smile? A new study shows no statistically significant link
between lead exposure and certain site-specific cancers in whites, but addi-
tional research is needed to confirm that the findings are truly valid.
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